For: | Singal AK, Salameh H, Singal A, Jampana SC, Freeman DH, Anderson KE, Brunder D. Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physicians. World J Gastrointest Pharmacol Ther 2013; 4(2): 16-22 [PMID: 23667769 DOI: 10.4292/wjgpt.v4.i2.16] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v4/i2/16.htm |
Number | Citing Articles |
1 |
Mark R. Thursz, Paul Richardson, Michael Allison, Andrew Austin, Megan Bowers, Christopher P. Day, Nichola Downs, Dermot Gleeson, Alastair MacGilchrist, Allister Grant, Steven Hood, Steven Masson, Anne McCune, Jane Mellor, John O’Grady, David Patch, Ian Ratcliffe, Paul Roderick, Louise Stanton, Nikhil Vergis, Mark Wright, Stephen Ryder, Ewan H. Forrest. Prednisolone or Pentoxifylline for Alcoholic Hepatitis. New England Journal of Medicine 2015; 372(17): 1619 doi: 10.1056/NEJMoa1412278
|
2 |
Bashar S. Hmoud, Kershaw Patel, Ramon Bataller, Ashwani K. Singal. Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta‐analysis of randomized trials. Liver International 2016; 36(5): 721 doi: 10.1111/liv.12939
|
3 |
Ashwani K. Singal, Vijay H. Shah. Zakim and Boyer's Hepatology. 2018; : 351 doi: 10.1016/B978-0-323-37591-7.00024-0
|
4 |
Muhammad Baig, Saqib Walayat, Sonu Dhillon, Srinivas Puli. Efficacy of Granulocyte Colony Stimulating Factor in Severe Alcoholic Hepatitis: A Systematic Review and Meta-Analysis. Cureus 2020; doi: 10.7759/cureus.10474
|
5 |
Pranav Penninti, Ayooluwatomiwa D. Adekunle, Ashwani K. Singal. Alcoholic Hepatitis. Medical Clinics of North America 2023; 107(3): 533 doi: 10.1016/j.mcna.2022.12.005
|
6 |
Loretta Jophlin, Ashwani K. Singal. Liver Biopsy in Patients With Alcohol-Associated Liver Disease With Acute-on-Chronic Liver Failure. Journal of Clinical and Experimental Hepatology 2022; 12(2): 544 doi: 10.1016/j.jceh.2021.08.009
|
7 |
Virendra Singh, Amarjit Keisham, Ashish Bhalla, Navneet Sharma, Ritesh Agarwal, Ratiram Sharma, Akash Singh. Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic Hepatitis. Clinical Gastroenterology and Hepatology 2018; 16(10): 1650 doi: 10.1016/j.cgh.2018.01.040
|
8 |
Mohamed Shoreibah, Bhupinderjit S Anand, Ashwani K Singal. Alcoholic hepatitis and concomitant hepatitis C virus infection. World Journal of Gastroenterology 2014; 20(34): 11929-11934 doi: 10.3748/wjg.v20.i34.11929
|
9 |
Ewan Forrest, Gemma Petts, Andrew Austin, Kirsty Lloyd, Mark Wright, Nikhil Vergis, Stephen Atkinson, Steven Masson, David Patch, Alberto Quaglia, Mark Thursz, Robert Goldin. The diagnostic and prognostic significance of liver histology in alcoholic hepatitis. Alimentary Pharmacology & Therapeutics 2021; 53(3): 426 doi: 10.1111/apt.16157
|
10 |
Ashwani K Singal, Ramon Bataller, Joseph Ahn, Patrick S Kamath, Vijay H Shah. ACG Clinical Guideline: Alcoholic Liver Disease. American Journal of Gastroenterology 2018; 113(2): 175 doi: 10.1038/ajg.2017.469
|
11 |
Jacob Haiar, Ashwani K. Singal. Editorial: liver biopsy in alcoholic hepatitis—more clarity on when it may be needed. Alimentary Pharmacology & Therapeutics 2021; 53(5): 630 doi: 10.1111/apt.16173
|
12 |
Prednisolone or Pentoxifylline for Alcoholic Hepatitis. New England Journal of Medicine 2015; 373(3): 281 doi: 10.1056/NEJMc1506342
|
13 |
Ashwani K. Singal, Vijay H. Shah. Current trials and novel therapeutic targets for alcoholic hepatitis. Journal of Hepatology 2019; 70(2): 305 doi: 10.1016/j.jhep.2018.10.026
|
14 |
Mohamed A. Abdallah, Ashwani K. Singal. Editorial: biomarkers to optimise and personalise corticosteroid use among patients with severe alcoholic hepatitis—the search continues. Alimentary Pharmacology & Therapeutics 2019; 50(4): 462 doi: 10.1111/apt.15399
|
15 |
Ashwani K. Singal, Sudha Kodali, Lee A. Vucovich, Victor Darley-Usmar, Thomas D. Schiano. Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review. Alcoholism: Clinical and Experimental Research 2016; 40(7): 1390 doi: 10.1111/acer.13108
|
16 |
Ashwani K. Singal, Heer Mehta, Ana Clemente-Sanchez, Juan P. Arab, Winston Dunn, Ramon Bataller. Hepatology. 2025; : 761 doi: 10.1016/B978-0-443-26711-6.00028-7
|
17 |
Vijay H. Shah. Managing alcoholic liver disease. Clinical and Molecular Hepatology 2015; 21(3): 212 doi: 10.3350/cmh.2015.21.3.212
|
18 |
Ashwani K. Singal, Alexandre Louvet, Vijay H. Shah, Patrick S. Kamath. Grand Rounds: Alcoholic Hepatitis. Journal of Hepatology 2018; 69(2): 534 doi: 10.1016/j.jhep.2018.05.001
|
19 |
Anurag Lavekar, Deepak Suvarna, Aradya V, Nandeesh P, Vijayakumar R, Rithesh Reddy. A Randomised Double-Blind Trial of Pentoxifylline Alone versus Pentoxifylline Plus N Acetyl Cysteine in the Treatment of Severe Alcoholic Hepatitis in a Tertiary Care Hospital in Mysore, Karnataka. Journal of Evidence Based Medicine and Healthcare 2021; 8(8): 399 doi: 10.18410/jebmh/2021/78
|
20 |
Ashwani K. Singal, Paul Kwo, Allison Kwong, Suthat Liangpunsakul, Alexandre Louvet, Pranoti Mandrekar, Craig McClain, Jessica Mellinger, Gyongyi Szabo, Norah Terrault, Mark Thursz, Gerald S. Winder, W. Ray Kim, Vijay H. Shah. Research methodologies to address clinical unmet needs and challenges in alcohol‐associated liver disease. Hepatology 2022; 75(4): 1026 doi: 10.1002/hep.32143
|
21 |
Juan Pablo Arab, Marco Arrese, Ashwani K. Singal. Diagnosis of Alcohol-Associated Hepatitis. Clinics in Liver Disease 2021; 25(3): 571 doi: 10.1016/j.cld.2021.03.003
|
22 |
Mark Thursz, Timothy R. Morgan. Treatment of Severe Alcoholic Hepatitis. Gastroenterology 2016; 150(8): 1823 doi: 10.1053/j.gastro.2016.02.074
|
23 |
Mark Thursz, Ewan Forrest, Paul Roderick, Christopher Day, Andrew Austin, John O’Grady, Stephen Ryder, Michael Allison, Dermot Gleeson, Anne McCune, David Patch, Mark Wright, Steven Masson, Paul Richardson, Luke Vale, Jane Mellor, Louise Stanton, Megan Bowers, Ian Ratcliffe, Nichola Downs, Scott Kirkman, Tara Homer, Laura Ternent. The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial. Health Technology Assessment 2015; 19(102): 1 doi: 10.3310/hta191020
|